IRIS - Res&Arch Institutional Research Information System - Research & Archive

URBANI, GINEVRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 603
NA - Nord America 574
EU - Europa 338
SA - Sud America 93
Continente sconosciuto - Info sul continente non disponibili 37
AF - Africa 15
OC - Oceania 1
Totale 1.661
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 528
SG - Singapore 233
IT - Italia 122
CN - Cina 94
HK - Hong Kong 82
BR - Brasile 66
BD - Bangladesh 52
RU - Federazione Russa 51
KR - Corea 40
VN - Vietnam 38
DE - Germania 32
CA - Canada 24
IE - Irlanda 24
FR - Francia 21
FI - Finlandia 20
IN - India 13
AT - Austria 12
GB - Regno Unito 11
NL - Olanda 10
IQ - Iraq 9
PL - Polonia 9
CO - Colombia 8
MX - Messico 8
PK - Pakistan 8
AR - Argentina 7
SA - Arabia Saudita 7
SE - Svezia 7
ZA - Sudafrica 7
EC - Ecuador 6
TR - Turchia 6
CR - Costa Rica 5
ID - Indonesia 5
UA - Ucraina 5
JP - Giappone 4
BO - Bolivia 3
BZ - Belize 3
ES - Italia 3
CI - Costa d'Avorio 2
GP - Guadalupe 2
KW - Kuwait 2
RO - Romania 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AI - Anguilla 1
AU - Australia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
KZ - Kazakistan 1
LT - Lituania 1
MA - Marocco 1
MK - Macedonia 1
MU - Mauritius 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
YT - Mayotte 1
Totale 1.624
Salva come PNG Salva come JPEG
Città #
Singapore 181
Ashburn 85
San Jose 85
Hong Kong 82
Perugia 44
Seoul 39
Santa Clara 32
Beijing 22
Dublin 22
Moscow 22
Munich 22
Boardman 20
New York 20
Piscataway 19
Lauterbourg 18
Los Angeles 17
Hanoi 14
Chandler 12
Phoenix 10
Ho Chi Minh City 9
São Paulo 9
The Dalles 9
Turku 9
Hefei 8
Helsinki 8
Naples 8
Warsaw 8
Amsterdam 7
Brooklyn 7
Council Bluffs 7
Dallas 7
Montreal 7
Baghdad 6
Buffalo 6
Stockholm 6
Toronto 6
Vienna 6
Florence 5
Milan 5
Querétaro 5
San José 5
Seattle 5
Vicenza 5
Denver 4
Johannesburg 4
Nuremberg 4
Orem 4
Poplar 4
Rome 4
Tokyo 4
Atlanta 3
Bologna 3
Brasília 3
Chicago 3
Curitiba 3
Fortaleza 3
Jeddah 3
Lahore 3
Lappeenranta 3
Mexico City 3
Miami 3
New Delhi 3
San Francisco 3
Turin 3
Abidjan 2
As Sālimīyah 2
Bangkok 2
Bogotá 2
Calgary 2
Cape Town 2
Catania 2
Charlotte 2
Chennai 2
Cochabamba 2
Empoli 2
Frankfurt am Main 2
Guayaquil 2
Houston 2
Irpin 2
Istanbul 2
Karachi 2
Philadelphia 2
Pittsburgh 2
Prato 2
Qingdao 2
Quito 2
Riyadh 2
Santa Rosa 2
Sorocaba 2
Vancouver 2
Addis Ababa 1
Ahmedabad 1
Alagoinhas 1
Albuquerque 1
Ambato 1
Ambāla 1
Ankara 1
Anyang 1
Araraquara 1
Araxá 1
Totale 1.061
Salva come PNG Salva come JPEG
Nome #
Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases 109
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease 106
Allo-lithocholic acid, a microbiome derived secondary bile acid, attenuates liver fibrosis 91
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH 89
Bile acids and bile acid activated receptors in the treatment of Covid-19 87
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease 86
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer 85
Liver GPBAR1 Associates With Immune Dysfunction in Primary Sclerosing Cholangitis and Its Activation Attenuates Cholestasis in Abcb4−/− Mice 85
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma 83
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling 80
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 78
Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis 77
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis 71
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism 70
Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis 70
Immunology of bile acids regulated receptors 66
Bile Acids-Based Therapies for Primary Sclerosing Cholangitis: Current Landscape and Future Developments 60
Phenotyping the Chemical Communications of the Intestinal Microbiota and the Host: Secondary Bile Acids as Postbiotics 60
Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4 −/− mice 55
Current Landscape and Evolving Therapies for Primary Biliary Cholangitis 47
Obeticholic Acid and Other Farnesoid-X-Receptor (FXR) Agonists in the Treatment of Liver Disorders 36
LIFR antagonism reverses epithelial pro-CAF programs in pancreatic ductal adenocarcinoma 27
A bile acid–GPBAR1 network supports anti-inflammatory and anti-fibrotic benefits of probiotics in colitis 25
Bile acids as mediators of microbiota signaling in entero-hepatic disorders 13
The Farnesoid X receptor-bile acid axis contributes to immune evasion in gastric cancer and its inhibition enhances efficacy of anti-PD-L1 therapy 5
Totale 1.661
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.729
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.729
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202384 4 1 0 4 10 12 0 4 46 0 0 3
2023/202493 2 2 2 2 10 2 20 12 19 4 11 7
2024/2025377 6 29 20 25 23 36 17 46 66 21 54 34
2025/20261.008 69 68 59 163 118 62 125 42 103 84 63 52
2026/202799 38 48 13 0 0 0 0 0 0 0 0 0
Totale 1.661